ProfileGDS4718 / 228080_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 43% 56% 96% 55% 63% 52% 61% 55% 57% 50% 51% 64% 58% 61% 59% 67% 57% 67% 62% 77% 58% 55% 53% 57% 51% 50% 63% 55% 58% 44% 52% 81% 61% 52% 75% 66% 46% 71% 53% 96% 53% 61% 85% 56% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.1209443
GSM549102patient 115, normal, homogenized [OPG study]5.901856
GSM549104patient 119, normal, homogenized [OPG study]10.736296
GSM549108patient 138, normal, homogenized [OPG study]5.811455
GSM549119patient 077, normal, homogenized [OPG study]6.303963
GSM549133patient 032, cancer, homogenized [OPG study]5.6124652
GSM549139patient 042, cancer, homogenized [OPG study]6.2012461
GSM549099patient 107, normal, homogenized [OPG study]5.7877455
GSM549109patient 139, normal, homogenized [OPG study]5.9625457
GSM549110patient 046, normal, homogenized [OPG study]5.5038350
GSM549114patient 063, normal, homogenized [OPG study]5.5302151
GSM549122patient 082, normal, homogenized [OPG study]6.4446164
GSM549134patient 033, cancer, homogenized [OPG study]5.985758
GSM549136patient 036, cancer, homogenized [OPG study]6.1696461
GSM549140patient 044, cancer, homogenized [OPG study]6.0138259
GSM549111patient 047, normal, homogenized [OPG study]6.6638367
GSM549113patient 057, normal, homogenized [OPG study]5.8684557
GSM549132patient 031, cancer, homogenized [OPG study]6.6602567
GSM549137patient 038, cancer, homogenized [OPG study]6.3014462
GSM549142patient 047, cancer, homogenized [OPG study]7.3657177
GSM549100patient 110, normal, homogenized [OPG study]6.0006658
GSM549107patient 135, normal, homogenized [OPG study]5.778255
GSM549115patient 068, normal, homogenized [OPG study]5.6332753
GSM549116patient 072, normal, homogenized [OPG study]5.9494757
GSM549120patient 078, normal, homogenized [OPG study]5.5525151
GSM549131patient 030, cancer, homogenized [OPG study]5.4735650
GSM549118patient 074, normal, homogenized [OPG study]6.3393763
GSM549129patient 027, cancer, homogenized [OPG study]5.8541355
GSM549123patient 088, normal, homogenized [OPG study]5.9744158
GSM549124patient 006, cancer, homogenized [OPG study]5.2405344
GSM549126patient 015, cancer, homogenized [OPG study]5.5911252
GSM549128patient 025, cancer, homogenized [OPG study]8.0069481
GSM549103patient 117, normal, homogenized [OPG study]6.1795461
GSM549117patient 073, normal, homogenized [OPG study]5.5581452
GSM549138patient 041, cancer, homogenized [OPG study]7.341275
GSM549141patient 045, cancer, homogenized [OPG study]6.5976466
GSM549130patient 028, cancer, homogenized [OPG study]5.3156346
GSM549101patient 111, normal, homogenized [OPG study]6.9921371
GSM549105patient 128, normal, homogenized [OPG study]5.7031353
GSM549106patient 134, normal, homogenized [OPG study]10.726796
GSM549112patient 048, normal, homogenized [OPG study]5.6748353
GSM549125patient 011, cancer, homogenized [OPG study]6.215561
GSM549127patient 024, cancer, homogenized [OPG study]8.381985
GSM549135patient 035, cancer, homogenized [OPG study]5.8408856